Why Meds KLOW follows KLOW peptide into tissue

Why this question interests me

A skin experiment that measured both passage and retention was enough to unsettle my assumption that absorption was a simple yes-or-no question. Copper could cross prepared skin and also remain in it. The place where a substance ends up can be as revealing as the amount applied.

That is why Meds KLOW exists: the blend's repair claims led me to the physical work of reaching a tissue. Several component experiments persuade me; a whole-body benefit from mixing them remains a much larger leap. A well-designed human blend trial could change that judgement.

The surprise is how much work happens between naming a molecule and observing a result: a membrane, a transporter, a material that keeps the preparation close to tissue. I regard those delivery obstacles as research questions worth solving. A useful result, for me, would connect the preparation, the tissue it reached and a measured change in function. They also make a general claim about healing feel premature.

The Meds KLOW name

Meds KLOW is the name of this editorial site. I lack medical qualifications, and these pages offer no medical advice. There is no prescribing service here, no stock to purchase and no appointment calendar; products are neither sold nor dispatched through this site.

The published experiments are absorbing enough on their own. A clinician who can assess the individual person has a different responsibility from anything these pages can provide.

Corrections

An incorrect compound name can change the meaning of a whole paragraph. An incorrect population can do the same. The contact page explains which details help check a disputed statement or a source I have missed.